Metabolic syndrome appears to have little impact on sexual function in middle- to old-aged women, according to a study published online Jan. 14 in the Journal of Sexual Medicine.
TUESDAY, Feb. 8 (HealthDay News) -- Metabolic syndrome appears to have little impact on sexual function in middle- to old-aged women, according to a study published online Jan. 14 in the Journal of Sexual Medicine.
Yun Hwan Kim, M.D., Ph.D., of the Ewha Woman's University in Seoul, South Korea, and colleagues investigated the impact of metabolic syndrome on female sexual dysfunction in middle- to old-aged women. They studied 773 sexually active women aged 40 years and older who visited a health-screening clinic between May 2009 and January 2010. The participants' histories and anthropomorphic measurements were recorded. They also completed a series of laboratory tests and questionnaires. The main outcome measure was the Female Sexual Function Index (FSFI), which was used to assess the key dimensions of female sexual function.
The researchers found that, although there were significant differences in the demographics of women with and without metabolic syndrome, their frequency of sexual dysfunction was similar (52.1 and 55.1 percent, respectively). They saw little difference in the FSFI scores between the women with metabolic syndrome and those without. In multivariate logistic regression, metabolic syndrome and most of its components were not associated with female sexual dysfunction; however, menopausal status, smoking, depression, and symptomatic urinary incontinence were independent risk factors for female sexual dysfunction (P < 0.05). The overall rates of metabolic syndrome and female sexual dysfunction were 12.2 and 54.7 percent, respectively.
"In conclusion, metabolic syndrome may have little impact on sexual function in middle- to old-aged women," the authors write.
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
FDA approves Visby’s test for at-home STI identification
Published: March 28th 2025 | Updated: March 28th 2025The FDA has approved Visby Medical’s at-home sexually transmitted infection test, allowing women to screen for chlamydia, gonorrhea, and trichomoniasis without a prescription.
Read More
Low creatinine-to-cystatin C ratio linked to postmenopausal muscle loss
March 20th 2025A new study finds that postmenopausal women with a reduced creatinine-to-cystatin C ratio experience decreased muscle volume and slower walking speed, highlighting its role as a potential biomarker for muscle health.
Read More